Literature DB >> 962223

Reversible restrictive lung disease stimulating asthma.

D W Hudgel, D Cooper, J Souhrada.   

Abstract

A young adult woman presented with spontaneous and exercise-induced episodic dyspnea without wheezing. During dyspneic episodes all static lung volumes decreased markedly, the inspiratory capacity fell from 3.0 to 1.1 litres and total lung capacity from 5.3 to 2.6 litres. Airway resistance (Raw) remained normal, and maximal expiratory flows at low absolute lung volume actually increased. Static compliance decreased from 0.153 to 0.077 litre/cmH2O, and the elastic recoil increased from 2.8 to 4.8 cmH2O at 50% of baseline total lung capacity when dyspneic. Upstream airway resistance (Rus) remained unchanged, 1.7 cmH2O/litre/sec. All physiologic variables indicated a reversible restrictive process exists, the origin of which is unclear. It is concluded that the episodic increase in elastic recoil properties results in [1] loss of volume primarily in the alveolar ducts and sacs, [2] preservation of normal Rus by an increase in driving pressure, and [3] maintenance of normal Raw by stabilization of larger airways.

Entities:  

Mesh:

Year:  1976        PMID: 962223     DOI: 10.7326/0003-4819-85-3-328

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  3 in total

1.  Lessons from the World Trade Center disaster: airway disease presenting as restrictive dysfunction.

Authors:  Kenneth I Berger; Joan Reibman; Beno W Oppenheimer; Ioannis Vlahos; Denise Harrison; Roberta M Goldring
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

2.  Reactive airways dysfunction syndrome presenting as a reversible restrictive defect.

Authors:  R Gilbert; J H Auchincloss
Journal:  Lung       Date:  1989       Impact factor: 2.584

3.  Bronchial responsiveness in patients with restrictive spirometry.

Authors:  Jean I Keddissi; Marwan K Elya; Saif U Farooq; Houssein A Youness; Kellie R Jones; Ahmed Awab; Gary T Kinasewitz
Journal:  Biomed Res Int       Date:  2013-08-18       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.